CCRL2 Monoclonal antibody

CCRL2 Monoclonal Antibody for WB, IHC, ELISA

Host / Isotype

Mouse / IgG1


Human and More (1)







Cat no : 66611-1-Ig


C C chemokine receptor like 2, CCR11, CCR6, CCRL2, Chemokine receptor CCR11, Chemokine receptor X, CKRX, CRAM, CRAM A, CRAM B, HCR

Tested Applications

Positive WB detected inHeLa cells, K-562 cells
Positive IHC detected inhuman spleen tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

Western Blot (WB)WB : 1:1000-1:6000
Immunohistochemistry (IHC)IHC : 1:400-1:1600
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Published Applications

WBSee 4 publications below

Product Information

66611-1-Ig targets CCRL2 in WB, IHC, ELISA applications and shows reactivity with Human samples.

Tested Reactivity Human
Cited Reactivityhuman
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Immunogen CCRL2 fusion protein Ag4045
Full Name chemokine (C-C motif) receptor-like 2
Calculated Molecular Weight 344 aa, 40 kDa
Observed Molecular Weight 47 kDa
GenBank Accession NumberBC025717
Gene Symbol CCRL2
Gene ID (NCBI) 9034
Conjugate Unconjugated
Form Liquid
Purification MethodProtein G purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Chemokine CC motif receptor-like 2 (CCRL2) is a seven-transmembrane domain receptor that shares structural and functional similarities with the family of atypical chemokine receptors (ACKRs) (PMID: 28743719). CCRL2 does not appear to be a signaling receptor, but may have a role in modulating chemokine-triggered immune responses by capturing and internalizing CCL19 or by presenting RARRES2 ligand to CMKLR1, a functional signaling receptors. CCRL2 has been found on almost all hemopoietic cells, including monocytes, macrophages, polymorphonuclear neutrophils (PMNs), T cells, dendritic cells, natural killer cells, and CD34+ progenitor cells, with PMNs expressing the highest levels (PMID: 15188357). CCRL2 is also expressed by barrier cells, such as lymphatic and blood endothelial cells and bronchial and intestinal epithelial cells (PMID: 29056935).


Product Specific Protocols
WB protocol for CCRL2 antibody 66611-1-IgDownload protocol
IHC protocol for CCRL2 antibody 66611-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols




Statins Prevent the Deleterious Consequences of Placental Chemerin Upregulation in Preeclampsia

Authors - Lunbo Tan

PLoS Pathog

Identification of viral SIM-SUMO2-interaction inhibitors for treating primary effusion lymphoma.

Authors - Ling Ding

Onco Targets Ther

Oncogenic Role and Prognostic Value of MicroRNA-937-3p in Patients with Breast Cancer.

Authors - Deyu Li

Front Immunol

Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis

Authors - Tianming Zhao